Skip to main content
. 2012 Dec 26;7(12):e52796. doi: 10.1371/journal.pone.0052796

Figure 4. Probability of relapse-free survival as a function of CD markers count for 102 patients with invasive ductal carcinoma.

Figure 4

CD3 count (A), CD20 count (B), CD68 count (C) and CD68/(CD3+CD20) ratio (D).